title: In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
abstract: The aim of the present study was to evaluate the in vitro activity and cytotoxicity of meglumine antimoniate microspheres produced by spray drying on Leishmania infantum and the effect of the excipients used in them. The parasite strain shows sensitivity to the meglumine antimoniate microspheres prepared. All the antimony IC50 values from encapsulated meglumine antimoniate (3.80 +/- 0.34 to 9.53 +/- 0.70 microg SbV/ml for promastigotes assay) are considerably lower compared to the mean value of IC50 in Glucantime solution (112 +/- 12.74 microg SbV/ml). Interesting IC50 values for the excipient chitosan (112.64 +/- 0.53 mg/ml for promastigotes and 100.81 +/- 26.45 mg/ml for amastigotes) were obtained (without cytotoxic activity), whereas the rest of the excipients did not show any activity. This new delivery system could offer a new pharmacological tool for the treatment of leishmaniosis that reduces the doses required, lowering toxic side effects because of meglumine antimoniate.
authors.affiliation: Unit of Pharmaceutical Technology, Facultat de Farmàcia, Universitat de Barcelona, Avda. Joan XXIII s/n, 08028 Barcelona, Spain.
authors.forename: G
authors.initials: G
authors.lastname: Pujals
authors.forename: J M
authors.initials: JM
authors.lastname: Suñé-Negre
authors.forename: P
authors.initials: P
authors.lastname: Pérez
authors.forename: E
authors.initials: E
authors.lastname: García
authors.forename: M
authors.initials: M
authors.lastname: Portus
authors.forename: J R
authors.initials: JR
authors.lastname: Tico
authors.forename: M
authors.initials: M
authors.lastname: Miñarro
authors.forename: J
authors.initials: J
authors.lastname: Carrió
mesh_terms: D000818:Animals; D000965:Antimony / Q000494:pharmacology / Q000633:toxicity; D000981:Antiprotozoal Agents / Q000494:pharmacology* / Q000633:toxicity*; D002478:Cells, Cultured; D048271:Chitosan / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D020128:Inhibitory Concentration 50; D018314:Leishmania infantum / Q000187:drug effects*; D017737:Macrophages, Peritoneal / Q000187:drug effects; D008536:Meglumine / Q000494:pharmacology* / Q000633:toxicity*; D000077485:Meglumine Antimoniate; D051379:Mice; D008863:Microspheres; D009942:Organometallic Compounds / Q000494:pharmacology* / Q000633:toxicity*; D021261:Parasitic Sensitivity Tests
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D048271:Chitosan; D000965:Antimony